Daniel Janney, an insider at Krystal Biotech, Inc. (KRYS), executed a series of stock sales between February 24th and February 26th, 2026. In total, Janney sold 11,673 shares at an average price of approximately $266.97 per share, realizing proceeds of over $3.1 million.
The transactions included multiple sales on February 26th, totaling 7,741 shares for over $2.1 million. Prior to this, on February 24th, Janney sold 3,619 shares for more than $959,000, and on February 25th, an additional 700 shares were sold for $192,500.
While insider sales can occur for various reasons, including diversification or tax planning, they are closely monitored by the market. Krystal Biotech, Inc. is a biotechnology company focused on developing and commercializing gene therapies.